CRI-ENCI Ninth International Cancer
Immunotherapy Conference

TRANSLATING
SCIENCE INTO
SURVIVAL

Sept. 10-12, 2025 | Utrecht, The Netherlands

Pre-Conference Program: Sept. 9, 2025

CICON25 Abstract Submission

Abstract Submission has closed.
Thank you to all who submitted.

You can download the CICON25 Abstract Booklet here starting Wednesday, September 17, 2025.

RESTRICTED ACCESS

ABSTRACT SUBMISSION CATEGORIES

New Targets and Lead Structures
Submit your abstract in this session if you report on an exciting new target structure, or if you work on the development of innovative lead structures or therapeutic platforms.

Tumor Microenvironment and Immunosuppression
This session is dedicated to the complexity of cancer-immune interactions in the tumor microenvironment and to understanding the suppressive mechanisms that constrain anti-tumor immune responses.

Computational Immunology
Computational immunology is all about developing and utilizing computational tools that help us to analyze large amounts of data and harnessing AI models to improve cancer immunotherapy.

Cellular Therapies
From T-cell receptor treatments to chimeric antigen receptor innovations and beyond: This category covers all approaches in cellular therapy, encompassing diverse cell types and therapeutic strategies.

Biomarker Strategies
Accurate biomarkers are essential for the successful translation of cancer immunotherapies. If you have novel insights into predicting treatment-related effects such as response and toxicity, we encourage you to submit your abstract under this category.

 

Presenting your work

All accepted abstracts are presented as posters. Through a blind evaluation by our abstract review committee members, highly rated abstracts are proffered for consideration as short talk presentations.


Please download the Presentation Guidelines above for additional information.